Best Allogenic Bone Marrow Transplantation From A Related Donor Doctors Abroad for Australian Patients

Professor Zafer Gulbas has performed over 3,000 bone marrow transplants and leads one of Europe's largest transplantation centres at Anadolu Medical Center.

• Trained at the world-renowned MD Anderson Cancer Center and Fred Hutchinson Cancer Research Center
• Specialises in related and unrelated allogenic transplants for complex blood cancers
• Collaborates with Johns Hopkins Medicine International to maintain global treatment standards
• Published over 260 scientific papers on hematological oncology and transplant outcomes
• Member of the European Hematology Association and European Society for Medical Oncology

Professor Betul Tavil has performed over 1,100 paediatric procedures and led the bone marrow transplantation programmes at some of Turkey's top medical universities.

• Performed more than 100 successful hematopoietic stem cell transplantations for children
• Recognised by the Turkish Hematology Society for success in treating paediatric blood cancers
• Specialises in allogenic transplants for rare genetic blood disorders and immunodeficiencies
• Authored 147 scientific publications on childhood leukaemia and stem cell therapy
• Active member of the Eastern Mediterranean Paediatric Oncology Group

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.

• Specializes in the treatment of testicular, ovarian, and head and neck cancers.
• Performs oncology procedures including chemotherapy, immunotherapy, and targeted therapy.
• Trained at Hacettepe University and Istanbul Sisli Etfal Training Hospital.
• Practices at a JCI-accredited facility that treats over 500,000 patients annually.

Professor Omur Gokmen Sevindik completed a prestigious fellowship at the Mayo Clinic in the United States, specialising in advanced stem cell transplantation. He currently leads the hematology team at Istanbul Florence Nightingale Hospital.

• Served as the Chair of the Multiple Myeloma Scientific Subcommittee
• Published over 100 articles in international peer-reviewed journals on blood cancers
• Specialises in treating complex hematological malignancies and stem cell disorders
• Active member of the European Hematology Association and Society of Hematologic Oncology

Professor Bulent Eser is a senior haematologist at Medical Park Antalya with a career-long focus on blood and marrow transplantation.

• Member of the European Group for Blood and Marrow Transplantation (EBMT)
• Serves as a Professor of Internal Medicine and Haematology
• Active member of the Turkish Society of Hematology
• Experienced in treating complex haematological conditions requiring donor transplants
• Dedicated specialist in the Hematologic Oncology Association for blood-based cancers

Professor Ceyhun Bozkurt is the Clinical Director of Pediatric Hematology-Oncology at Medical Park Bahcelievler, specialising in complex stem cell transplants for children.

• Trained at the Cincinnati Children's Hospital Pediatric Stem Cell Transplant Centre in the USA
• Observer at Harvard University's Dana-Farber Cancer Institute focusing on paediatric neuro-oncology
• Member of the European Bone Marrow Transplant Group (EBMT)
• Vice Director of the Stem Cell Transplant Unit at Istinye University
• Published over 40 scientific articles on paediatric leukaemia and immunodeficiency treatments

Professor Savas Kansoy is a pioneer in paediatric bone marrow transplantation, having founded several of Turkey's major transplant units during his career.

• Specialises in pediatric haematology and oncology at the renowned Anadolu Medical Center
• Former Co-Chair of the Bone Marrow Transplantation Working Group for the Turkish Society of Paediatric Haematology
• Awarded for his research into stem cell antigens and thrombotic parameters in transplant patients
• Accredited by the European Group for Bone Marrow Transplantation (EBMT)

Dr. Gulumser Kiziltas Tokmak is a neurologist at Hisar Hospital Intercontinental in Istanbul. She holds a master’s degree in electrophysiology from Istanbul University. Dr. Tokmak specializes in brain health, treating conditions like dementia, chronic headaches, and vertigo. She works at a JCI-accredited facility known for international patient safety standards.

• Specializes in diagnostic studies including EMG, EEG, and polysomnography (PSG).
• Treats complex neurodegenerative disorders like Alzheimer’s, Parkinson’s, and multiple sclerosis.
• Manages specialized neurological therapies, including medication for essential tremors and ALS.
• Performs advanced diagnostic monitoring, such as video-EEG and electroneurography.

Professor Sebnem Izmir Guner is a heavyweight in haematology who has founded three separate adult bone marrow transplantation centres throughout her career.

• Specialises in treating leukaemia, lymphoma, and multiple myeloma through related-donor transplants
• Certified in therapeutic apheresis for advanced blood filtration and stem cell collection
• Professor at Istanbul University – one of Turkey's oldest and most prestigious medical institutions
• Published over 37 research articles in international and national peer-reviewed medical journals
• Holds memberships in major domestic haematology associations and received three academic excellence awards

Dr Toluy Ozgumus is a senior hematologist at Hisar Hospital Intercontinental with extensive experience in bone marrow transplantation and rare blood cancers.

• Completed specialist hematology fellowship training at Marmara University Department of Hematology
• Managed clinical care and diagnosis for over 900 patients with complex blood disorders
• Specialises in acute and chronic leukemias, lymphomas, and multiple myeloma treatment
• Expertise in handling all stages of the bone marrow transplantation process
• Focuses on managing clotting and bleeding disorders alongside oncological therapy